
Pharma Business - March 28, 2022
Orion is planning to refocus its R&D
Orion is planning to change and refocus the strategy of its R&D function and in the future focus would be on cancer and pain. Orion will initiate negotiations concerning in total 430 salaried employees and senior salaried employees in Finland in Espoo, Turku and Kuopio in the research areas in which investment would be discontinued […]

Uncategorized - February 2, 2021
Orion invests in the development of digital therapies
Orion’s digital therapies development projects play a role in the MASSE project with the purpose to create global exports of digital health innovations. Aalto University’s MASSE project, led by Professor Paul Lillrank, brings together academic research and business-driven innovation. The project focuses on the care pathways in long-term illnesses and how they could be improved and scaled […]